Sickle cell disease treatment trial

Israel’s BiolineRX is to conduct Phase 1 clinical trials on sickle cell disease (SCD) patients at multiple locations in the US.  It will use its motixafortide stem cell therapy (see previously), currently used to treat multiple myeloma. SCD is caused by a mutation of the hemoglobin gene.

Predicting what cancer cells will do next

Researchers at the Hebrew University of Jerusalem analyze cancer patient biopsies and use AI to predict disease progression or chemotherapy resistance. Using the science of nano-informatics, they expose cells to nano particles, record absorption levels, and model cellular behavior.

Restoring the sense of touch

Nerve damage in the hand results in loss of both motor and sensory capability. Surgery can restore movement, but not sensation. Israel’s Tengable has developed tiny sensors that are implanted under the skin. On touching an object, an electrical charge is transmitted to a healthy nerve-ending.

Clearly the best way through

Israel’s Veinway has developed Traversa - a literally revolutionary device that removes blockages in narrow veins caused by disease, clots, scar tissue etc. It can treat many of the 900,000 US patients diagnosed with Deep Vein Thrombosis (DVT). Compassionate use trials have been very successful.

3D-printing body parts

Since Oct 7, Israel’s Synergy3d Med has progressed from 3D-printing prosthetics for animals (see previously). Its Patient Specific Instruments (PSIs) create customized replacement limbs or implants of bones and joints for wounded Israelis, inside hospitals in a few hours. Also used in UK and Spain.

Caring for patients remotely

An updated article about Israel’s Laguna Health (see previously) whose AI platform records and analyzes conversations during telehealth consultations for social, emotional, and cultural context. It highlights issues enabling care managers to treat their hundreds of patients as individuals.

A virtual hospital

Israel’s Beilinson Hospital in Petah Tikva has launched a virtual medical center in line with a 25% increase in demand for telehealth services since Oct 7. The Beilinson NEXT service is available for no additional cost to all Israelis. They can be treated whilst in their kitchen or workplace.

Wearable devices can save lives

Dr. Shirit Kazum-Beiser is Head of the Sports Cardiology Clinic at Israel’s Beilinson Hospital. She said that smart technology accessories, such as smartwatches, provide data that cardiologists can use to advance research and development and, with new AI tools, can save many lives.

Transforming healthcare

The 150 innovative Israeli health-tech companies presenting at the 2024 BioMed Israel conference featured several new to this newsletter, including Epilog (companion app); Innoventric (valve replacement); Pangea Bio (AI oncology); and QRGenetics (AI therapy discovery).

One happy donkey

Miri, a 7-year-old female 3-legged donkey with an abscess under its hoof was in so much pain, that euthanasia was the only option. But after one injection of liposomal-CBD from Israel’s Innocan (see previously), Miri regained her mobility and the abscess healed.